TDOC
Undervalued by 207.8% based on the discounted cash flow analysis.
Market cap | $2.23 Billion |
---|---|
Enterprise Value | $2.65 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-1.34 |
Beta | 2.05 |
Outstanding Shares | 169,314,029 |
Avg 30 Day Volume | 4,353,112 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -10.13 |
---|---|
PEG | 10.2 |
Price to Sales | 0.92 |
Price to Book Ratio | 1.06 |
Enterprise Value to Revenue | 1.02 |
Enterprise Value to EBIT | -12.57 |
Enterprise Value to Net Income | -13 |
Total Debt to Enterprise | 0.58 |
Debt to Equity | 0.66 |
No data
No data
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized int...